Efficacy analysis of endostar combined with chemoradiotherapy and immune checkpoint inhibitors in locally advanced non-small cell lung cancer

Abstract Objective Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a leading cause of cancer-related death globally, with treatment challenges persisting in locally advanced or inoperable cases. To evaluate the efficacy and adverse reactions of recombinant human endostatin (End...

Full description

Bibliographic Details

Published in:	Discover Oncology
Main Authors:	Bo Li, Yaocheng Yang, Lina Dong, Dunmin Zhuang, Shixiang Pan, Haijun Lu
Format:	Article
Language:	English
Published:	Springer 2025-07-01
Subjects:	Non-small cell lung cancer Inoperable Locally advanced Recombinant human endostatin Intensity-modulated radiotherapy Immune checkpoint inhibitors
Online Access:	https://doi.org/10.1007/s12672-025-03044-7